Advanced search
Publication Cover
Expert Review of Anti-infective Therapy Volume 10, 2012 - Issue 3
Submit an article Journal homepage
91
Views
5
CrossRef citations to date
0
Altmetric
Drug Profile

Boceprevir: an oral protease inhibitor for the treatment of chronic HCV infection

Paul M Trembling Centre for Hepatology, UCL Medical School, Royal Free Hospital, Rowland Hill Street, London, NW3 2PF, UK
,
Sudeep Tanwar Centre for Hepatology, UCL Medical School, Royal Free Hospital, Rowland Hill Street, London, NW3 2PF, UK
&
Geoffrey M Dusheiko Centre for Hepatology, UCL Medical School, Royal Free Hospital, Rowland Hill Street, London, NW3 2PF, UK. [email protected]
Pages 269-279 | Published online: 10 Jan 2014

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Jianjian Fu & Jing Wei. (2015) Molecular dynamics study on drug resistance mechanism of HCV NS3/4A protease inhibitor: BI201335. Molecular Simulation 41:8, pages 674-682.
Read now

Articles from other publishers (4)

Samar Mohamed Abbas, Hend Mikhail Salama & Hebatallah Nour-Eldein. (2018) Depression among adults with chronic hepatitis C on antiviral treatment in Port-Said, Egypt. Journal of Public Health 26:6, pages 679-686.
Crossref
Naglaa F. A. Youssef, Mohamed El Kassas, Amany Farag & Ashley Shepherd. (2017) Health-related quality of Life in patients with chronic hepatitis C receiving Sofosbuvir-based treatment, with and without Interferon: a prospective observational study in Egypt. BMC Gastroenterology 17:1.
Crossref
Pegah Golabi, Mehmet Sayiner, Haley Bush, Lynn H. Gerber & Zobair M. Younossi. (2017) Patient-Reported Outcomes and Fatigue in Patients with Chronic Hepatitis C Infection. Clinics in Liver Disease 21:3, pages 565-578.
Crossref
Emma Gray, Suzanne Norris, Susanne Schmitz & Aisling O'Leary. (2017) Do disparities between populations in randomized controlled trials and the real world lead to differences in outcomes?. Journal of Comparative Effectiveness Research 6:1, pages 65-82.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.